Literature DB >> 19456852

Treatment of basal cell carcinoma.

Tino Wetzig1, Jan Maschke, Michael Kendler, Jan C Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19456852     DOI： 10.1111/j.1610-0387.2009.07097.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  7 in total

1.  Basal cell carcinoma.

Authors:  Christiane Matuschek; Norman Philipp Hoff; Matthias Peiper; Wilfried Budach; Peter Arne Gerber; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

2.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

3.  Multivariate analysis of the influence of patient-, tumor-, and management-related factors on the outcome of surgical therapy for facial basal-cell carcinoma.

Authors:  Cornelia Katharina Mueller; Kristin Nicolaus; Michael Thorwarth; Stefan Schultze-Mosgau
Journal:  Oral Maxillofac Surg       Date:  2010-09

4.  [Basal cell carcinoma of the face and scalp : An update on treatment options].

Authors:  B Frerich; F Prall
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

Review 5.  [Therapy of basal cell carcinoma].

Authors:  L Schmitz; T Dirschka
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

6.  Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease.

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2010-12-29

Review 7.  Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment.

Authors:  Waleska K Martins; Renata Belotto; Maryana N Silva; Daniel Grasso; Maynne D Suriani; Tayná S Lavor; Rosangela Itri; Mauricio S Baptista; Tayana M Tsubone
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.